These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
437 related articles for article (PubMed ID: 32012401)
1. Cisplatin-induced programmed cell death ligand-2 expression is associated with metastasis ability in oral squamous cell carcinoma. Sudo S; Kajiya H; Okano S; Sasaki M; Katsumata Y; Ohno J; Ikebe T; Hiraki A; Okabe K Cancer Sci; 2020 Apr; 111(4):1113-1123. PubMed ID: 32012401 [TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of PD-L2 expression in patients with oral squamous cell carcinoma-A comparison to the PD-L1 expression profile. Weber M; Wehrhan F; Baran C; Agaimy A; Büttner-Herold M; Kesting M; Ries J Cancer Med; 2019 Mar; 8(3):1124-1134. PubMed ID: 30659749 [TBL] [Abstract][Full Text] [Related]
3. MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-β1. Chen L; Zhu Q; Lu L; Liu Y Bioengineered; 2020 Dec; 11(1):91-102. PubMed ID: 31906769 [TBL] [Abstract][Full Text] [Related]
4. Exosomes containing miR-21 transfer the characteristic of cisplatin resistance by targeting PTEN and PDCD4 in oral squamous cell carcinoma. Liu T; Chen G; Sun D; Lei M; Li Y; Zhou C; Li X; Xue W; Wang H; Liu C; Xu J Acta Biochim Biophys Sin (Shanghai); 2017 Sep; 49(9):808-816. PubMed ID: 28910982 [TBL] [Abstract][Full Text] [Related]
5. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression. Wang X; Li H; Shi J Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988 [TBL] [Abstract][Full Text] [Related]
6. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance. Su L; Wang Y; Xiao M; Lin Y; Yu L Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995 [TBL] [Abstract][Full Text] [Related]
7. Regulation of PD-L1 expression in a high-grade invasive human oral squamous cell carcinoma microenvironment. Hirai M; Kitahara H; Kobayashi Y; Kato K; Bou-Gharios G; Nakamura H; Kawashiri S Int J Oncol; 2017 Jan; 50(1):41-48. PubMed ID: 27922697 [TBL] [Abstract][Full Text] [Related]
8. Knockdown of KPNA2 inhibits autophagy in oral squamous cell carcinoma cell lines by blocking p53 nuclear translocation. Lin F; Gao L; Su Z; Cao X; Zhan Y; Li Y; Zhang B Oncol Rep; 2018 Jul; 40(1):179-194. PubMed ID: 29781035 [TBL] [Abstract][Full Text] [Related]
9. Loss of Tumor Suppressor CYLD Expression Triggers Cisplatin Resistance in Oral Squamous Cell Carcinoma. Suenaga N; Kuramitsu M; Komure K; Kanemaru A; Takano K; Ozeki K; Nishimura Y; Yoshida R; Nakayama H; Shinriki S; Saito H; Jono H Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31635163 [TBL] [Abstract][Full Text] [Related]
10. A novel miR-365-3p/EHF/keratin 16 axis promotes oral squamous cell carcinoma metastasis, cancer stemness and drug resistance via enhancing β5-integrin/c-met signaling pathway. Huang WC; Jang TH; Tung SL; Yen TC; Chan SH; Wang LH J Exp Clin Cancer Res; 2019 Feb; 38(1):89. PubMed ID: 30782177 [TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and Prognostic Analysis of PD-L1 and PD-L2 Expression in Surgically Resected Primary Tongue Squamous Cell Carcinoma. Furukawa K; Kawasaki G; Yoshida T; Umeda M Anticancer Res; 2021 Jan; 41(1):101-111. PubMed ID: 33419803 [TBL] [Abstract][Full Text] [Related]
12. AIM2 promotes irradiation resistance, migration ability and PD-L1 expression through STAT1/NF-κB activation in oral squamous cell carcinoma. Chiu HW; Lee HL; Lee HH; Lu HW; Lin KY; Lin YF; Lin CH J Transl Med; 2024 Jan; 22(1):13. PubMed ID: 38166970 [TBL] [Abstract][Full Text] [Related]
13. HOXA1 silencing inhibits cisplatin resistance of oral squamous cell carcinoma cells via IκB/NF-κB signaling pathway. Zhu R; Mao Y; Xu X; Li Y; Zheng J Anticancer Drugs; 2024 Jul; 35(6):492-500. PubMed ID: 38477942 [TBL] [Abstract][Full Text] [Related]
14. Differential expression of programmed death-1 and its ligand, programmed death ligand-1 in oral squamous cell carcinoma with and without oral submucous fibrosis. Quan H; Liu S; Shan Z; Liu Z; Chen T; Hu Y; Yao Z; Fang L Arch Oral Biol; 2020 Nov; 119():104916. PubMed ID: 32977151 [TBL] [Abstract][Full Text] [Related]
15. WP1066 sensitizes oral squamous cell carcinoma cells to cisplatin by targeting STAT3/miR-21 axis. Zhou X; Ren Y; Liu A; Jin R; Jiang Q; Huang Y; Kong L; Wang X; Zhang L Sci Rep; 2014 Dec; 4():7461. PubMed ID: 25514838 [TBL] [Abstract][Full Text] [Related]
17. miR-21 inhibitor sensitizes human OSCC cells to cisplatin. Wang W; Songlin P; Sun Y; Zhang B; Jinhui W Mol Biol Rep; 2012 May; 39(5):5481-5. PubMed ID: 22249446 [TBL] [Abstract][Full Text] [Related]
18. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling. Lu M; Wang C; Chen W; Mao C; Wang J DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705 [TBL] [Abstract][Full Text] [Related]
19. Cisplatin-induced HSF1-HSP90 axis enhances the expression of functional PD-L1 in oral squamous cell carcinoma. Sasaya T; Kubo T; Murata K; Mizue Y; Sasaki K; Yanagawa J; Imagawa M; Kato H; Tsukahara T; Kanaseki T; Tamura Y; Miyazaki A; Hirohashi Y; Torigoe T Cancer Med; 2023 Feb; 12(4):4605-4615. PubMed ID: 36200687 [TBL] [Abstract][Full Text] [Related]
20. Licochalcone C induced apoptosis in human oral squamous cell carcinoma cells by regulation of the JAK2/STAT3 signaling pathway. Oh HN; Seo JH; Lee MH; Kim C; Kim E; Yoon G; Cho SS; Cho YS; Choi HW; Shim JH; Chae JI J Cell Biochem; 2018 Dec; 119(12):10118-10130. PubMed ID: 30129052 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]